Generic GA Shows Equivalence on MRI Endpoints in MSGeneric GA Shows Equivalence on MRI Endpoints in MS

A generic version of the MS drug glatiramer acetate looked similar to the branded product (Copaxone) in terms of reduction in MRI lesions and side effects in the GATE study. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news